Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma
AIM:To evaluate the effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma(CACG)and acute angle-closure glaucoma(AACG). <p>METHODS: Sixty-eyes of 45 cases with CACG or CACG were randomly divided into two groups. Thirty...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2013-09-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://www.ies.net.cn/cn_publish/2013/9/201309020.pdf |
_version_ | 1818286323651313664 |
---|---|
author | Qing-Hui Kong Xiao-Yan Dou Jiang Guo |
author_facet | Qing-Hui Kong Xiao-Yan Dou Jiang Guo |
author_sort | Qing-Hui Kong |
collection | DOAJ |
description | AIM:To evaluate the effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma(CACG)and acute angle-closure glaucoma(AACG). <p>METHODS: Sixty-eyes of 45 cases with CACG or CACG were randomly divided into two groups. Thirty-four eyes in IOL group underwent phacoemulsification plus intraocular lens(IOL)implantation. Twenty-six eyes in laser iridotomy(LI)group included treatment by LI. Intraocular pressure(IOP), numbers of antiglaucoma medications, complications, and corneal endothelial cell counts were examined in each group. <p>RESULTS: In IOL group, IOP was significantly reduced from a preoperative mean of 14.82±4.23mmHg to a 6-month postoperative mean of 10.94±1.24mmHg. However, in LI group, mean preoperative IOP was 15.34±4.13mmHg, and the 6-month postoperative IOP was 14.68±4.77mmHg. There was statistical significance in preoperative and postoperative IOP between two groups(<i>F</i>=36.452, <i>P</i><0.01). In IOL group, no patient used anti-glaucoma medications 6-month postoperatively, whereas in LI group, mean number of anti-glaucoma medications was 0.24±0.41(<i>P</i><0.05). There were no significant differences in preoperative and postoperative corneal endothelial cell counts between IOL and LI groups(<i>P</i>>0.05). <p>CONCLUSION: Primary phacoemulsification plus intraocular lens implantation for controlled CACG or AACG seems to be a safe and effective method in reducing IOP. This procedure might become the first treatment of choice for controlled CACG or AACG with cataract. |
first_indexed | 2024-12-13T01:22:42Z |
format | Article |
id | doaj.art-d8ca50460a9e4d338032b49dd6e633a9 |
institution | Directory Open Access Journal |
issn | 1672-5123 |
language | English |
last_indexed | 2024-12-13T01:22:42Z |
publishDate | 2013-09-01 |
publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
record_format | Article |
series | Guoji Yanke Zazhi |
spelling | doaj.art-d8ca50460a9e4d338032b49dd6e633a92022-12-22T00:04:12ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232013-09-011391807180910.3980/j.issn.1672-5123.2013.09.20Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucomaQing-Hui KongXiao-Yan DouJiang GuoAIM:To evaluate the effects and safety of primary phacoemulsification plus intraocular lens implantation for controlled chronic angle-closure glaucoma(CACG)and acute angle-closure glaucoma(AACG). <p>METHODS: Sixty-eyes of 45 cases with CACG or CACG were randomly divided into two groups. Thirty-four eyes in IOL group underwent phacoemulsification plus intraocular lens(IOL)implantation. Twenty-six eyes in laser iridotomy(LI)group included treatment by LI. Intraocular pressure(IOP), numbers of antiglaucoma medications, complications, and corneal endothelial cell counts were examined in each group. <p>RESULTS: In IOL group, IOP was significantly reduced from a preoperative mean of 14.82±4.23mmHg to a 6-month postoperative mean of 10.94±1.24mmHg. However, in LI group, mean preoperative IOP was 15.34±4.13mmHg, and the 6-month postoperative IOP was 14.68±4.77mmHg. There was statistical significance in preoperative and postoperative IOP between two groups(<i>F</i>=36.452, <i>P</i><0.01). In IOL group, no patient used anti-glaucoma medications 6-month postoperatively, whereas in LI group, mean number of anti-glaucoma medications was 0.24±0.41(<i>P</i><0.05). There were no significant differences in preoperative and postoperative corneal endothelial cell counts between IOL and LI groups(<i>P</i>>0.05). <p>CONCLUSION: Primary phacoemulsification plus intraocular lens implantation for controlled CACG or AACG seems to be a safe and effective method in reducing IOP. This procedure might become the first treatment of choice for controlled CACG or AACG with cataract.http://www.ies.net.cn/cn_publish/2013/9/201309020.pdfcataract phacoemulsificationintraocular lens implantationprimary angle-closure glaucoma |
spellingShingle | Qing-Hui Kong Xiao-Yan Dou Jiang Guo Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma Guoji Yanke Zazhi cataract phacoemulsification intraocular lens implantation primary angle-closure glaucoma |
title | Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma |
title_full | Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma |
title_fullStr | Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma |
title_full_unstemmed | Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma |
title_short | Clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle-closure glaucoma |
title_sort | clinical observation of primary phacoemulsification plus intraocular lens implantation for primary angle closure glaucoma |
topic | cataract phacoemulsification intraocular lens implantation primary angle-closure glaucoma |
url | http://www.ies.net.cn/cn_publish/2013/9/201309020.pdf |
work_keys_str_mv | AT qinghuikong clinicalobservationofprimaryphacoemulsificationplusintraocularlensimplantationforprimaryangleclosureglaucoma AT xiaoyandou clinicalobservationofprimaryphacoemulsificationplusintraocularlensimplantationforprimaryangleclosureglaucoma AT jiangguo clinicalobservationofprimaryphacoemulsificationplusintraocularlensimplantationforprimaryangleclosureglaucoma |